Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8835411 | 0.84 | — | — | |
| SCHEMBL4793302 | 0.81 | — | — | |
| SCHEMBL6223484 | 0.79 | — | — | |
| SCHEMBL17891350 | 0.78 | TSHR (0.32) | TSHRMAPK1 | |
| SCHEMBL10832324 | 0.77 | — | — | |
| SCHEMBL6894366 | 0.77 | — | — | |
| SCHEMBL1158383 | 0.77 | — | — | |
| SCHEMBL44498 | 0.77 | — | — | |
| SCHEMBL2840847 | 0.77 | — | — | |
| SCHEMBL170003 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023071998-A1 | NOVEL PYRIDO OR TRIAZINE-SUBSTITUTED PYRIDO HETEROCYCLIC COMPOUND | 杭州德睿智药科技有限公司 | 2023-05-04 | — | — | WO | claimed |
| WO-2018026812-A1 | ANTIVIRAL AGENTS | OHIO STATE INNOVATION FOUNDATION (US) | 2018-02-08 | — | — | WO | claimed |
| WO-2018026811-A2 | ANTIFUNGAL AGENTS | OHIO STATE INNOVATION FOUNDATION (US) | 2018-02-08 | — | — | WO | claimed |
| WO-2012113920-A1 | ARYLSULFONE DERIVATIVES WITH ACTIVITY AGAINST HUMAN BETAHERPESVIRUSES | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2012-08-30 | — | — | WO | claimed |
| EP-1676846-B1 | Hydantoin derivatives as MMP inhibitors | ASTRAZENECA AB (SE) | 2010-12-29 | — | — | EP | claimed |
| US-20080306065-A1 | Metalloproteinase Inhibitors | ASTRAZENECA AB (SE) | 2008-12-11 | — | — | US | claimed |
| US-20080262045-A1 | Metalloproteinase Inhibitors | ASTRAZENECA AB (SE) | 2008-10-23 | — | — | US | claimed |
| CN-101273157-A | Zinc-nickel alloy electroplating system | PAVCO INC (US) | 2008-09-24 | — | — | CN | claimed |
| US-7368465-B2 | Respiratory system disorders; antiarthritic agents; anticancer agents; bone disorders | ASTRAZENECA AB (SE) | 2008-05-06 | — | — | US | claimed |
| WO-2007002070-A2 | ZINC-NICKEL ALLOY ELECTROPLATING SYSTEM | PAVCO, INC. (US) | 2007-01-04 | — | — | WO | claimed |
| WO-2002074749-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | claimed |
| WO-2002074752-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | claimed |
| WO-2002074767-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | claimed |
| WO-2002074750-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | claimed |
| WO-2002074748-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | claimed |
| US-6291045-B1 | SUBSTRATES WITH DYE LAYER WITH TRIMETHINE CYANINE DYES, RECORDING AND READING, TREATMENT WITH LASER BEAM AND ULTRAVIOLET RADIATION | TAIYO YUDEN CO., LTD. (JP) | 2001-09-18 | — | — | US | claimed |
| US-6218072-B1 | CONTAINING CYANINE DYE | TAIYO YUDEN CO., LTD. (JP) | 2001-04-17 | — | — | US | claimed |
| US-5976658-A | CONTAINING TRIMETHINE-CYANINE DYE; RECORDING USING LASER | TAIYOYUDEN CO., LTD. (JP) | 1999-11-02 | — | — | US | claimed |
| EP-0919998-A1 | Optical information recording medium | TAIYO YUDEN CO., LTD. (JP) | 1999-06-02 | — | — | EP | claimed |
| EP-0840307-A2 | Optical information recording medium | Taiyoyuden Co., Ltd. (JP) | 1998-05-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306065-A1 | Metalloproteinase Inhibitors | MMP9, MMP12, MMP14 | TSHR 4080/4885ALDH1A1 612/4885CA1 93/4885 |
| US-20080262045-A1 | Metalloproteinase Inhibitors | MMP9, MMP12, MMP11 | TSHR 2145/4885ALDH1A1 1381/4885CA1 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.